Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and advisors are critical to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace. ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the European MSL & Medical/Scientific Advisor Best Practices conference was born. We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole. We look forward to greeting you in London!

1. REGISTER bY 17 SEPTEMbER FOR REDUcED PRIcING
Medical/Scientific Advisor
PROUDLY PRESENTS
and Medical Science Liaison
Best Practices
Bringing Maximum Value to the KOL,
Company and Industry
28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON
FEATURED SESSIONS INCLUDE:
Distinguished
Speaking Faculty DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SA
Exploring Similarities and Differences in Job Titles, Descriptions and
Joins Us From: Daily Activities of Medical Science Liaisons, Medical Advisors, and
Scientific Advisors across Companies and Countries
AMGEN Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global
ARNOLD & PORTER Medical Affairs, UCB PHARMA, Belgium
BAYER Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom
BRISTOL-MYERS SQUIBB INVESTIGATOR INITIATED TRIALS (IITs)
BRITISH PHARMACOPOEIA Outlining Best Practices for How MSLs and Advisors Can Best Support
COMMISSION the Successful Execution of IITs across the EU
FELTER CONSULTING LTD Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
FORMER GENENTECH KEY OPINION LEADER INITIATION AND DEVELOPMENT
GLAXOSMITHKLINE Effectively Managing Relationships to Meet the Needs and Objectives
LILLY of the KOL and the Company
PFIZER Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France
SANOFI-AVENTIS cAREER DEVELOPMENT
UCB Identifying Different Opportunities Available to Individuals with
AND MORE! MSL/Advisor Experience, Education Levels and Skills
Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC
AFFAIRS, United States
The Only Event Led by, and Designed for,
European Pharmaceutical, Biotech and
Medical Device Advisors and MSLs!
To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl

2. Medical/Scientific Advisor and Medical
Science Liaison Best Practices
28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON
WHo SHoUlD AttenD? Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a
critical function within Medical Affairs departments of pharmaceutical, biotech and medical
device companies. These typically highly educated and experienced professionals evaluate,
Professionals from Pharmaceutical, critique and communicate comprehensive scientific information related to a company’s
Biotechnology and Medical Device products. While differences in job titles, backgrounds and day-to-day activities can vary across
companies with responsibilities in the companies and regions, MSLs and Advisors are essential to improving understanding amongst
following areas: internal departments and supporting product awareness across the broader medical community.
They are credible peers on whom thought leaders can rely for current, objective and thorough
information about disease states and treatments. They assist clinical teams, often support and help
Departments/titles train the sales force, and develop relationships with key opinion leaders, among other activities.
• Medical Science Liaisons (MSLS, MLs) MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely
• Medical Advisors competitive European marketplace.
• Scientific Advisors
ExL Pharma’s MSL Best Practices conference has a long and established history in the United States,
• Medical Managers
with seven highly successful and valuable MSL events taking place throughout America over a five
• Medical Scientists year period. These conferences continue to attract more and more industry professionals, and have
• Medical Affairs solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical
• Scientific Affairs Affairs professionals. From the US-based events, a need was assessed for a similar conference
• Regional Medical Education Officers to take place in Europe. Thus, the Medical/Scientific Advisor and Medical Science Liaison Best
• Medical Communications Practices conference was born.
• Clinical Trial Liaisons We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the
• Clinical Research industry to gather to share successful strategies for both field-based and office-based activities.
• Medical Education Through the provision of case studies and educational presentations led by experienced industry
• Clinical/Outcomes Liaisons professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain
• Clinical Investigators take-home approaches for providing maximum value to key opinion leaders, the company and the
industry as a whole.
• KOL Development
• Business Intelligence We look forward to greeting you in London!
• Regulatory Affairs
• Marketing Sincerely,
this conference is also of interest to:
• Software and Technology Companies
• Staffing Agencies/Recruiters Lindsay Slater Kristen Hunter
• Law Firms Conference Director Team Leader, Production
• Consultants European Scientific/Medical Advisor ExL Pharma
and MSL Best Practices
VENUE INFORMATION
Ambassadors Bloomsbury
12 Upper Woburn PlaceLondon, UKWC1H 0HX
t +44 (0)20 7693 5400
f +44 (0)20 7388 9930
Ambassadors Bloomsbury is a stylish, contemporary hotel, which prides itself on exceptional standards of
customer service.
New rooms designed for comfort and style. Visionary conference suites. Cutting edge restaurant and bar.
Located just five minutes walk from both Euston and King’s Cross St Pancras stations (the Eurostar termi-
nal), Ambassadors Bloomsbury is ideally located for both business trips and short leisure breaks.
Please contact the hotel directly at +44 (0)20 7693 5400 to book your room. Please mention ExL Pharma
and the conference name to take advantage of the discount. You must book your room by 8th October
2010 to be eligible for the discounted rate. Please book your room early as the rooms available at this rate
are limited and review your hotel confirmation to ensure that you received the ExL group rate.

3. Thursday, 28 October
PRE-CONFERENCE WORKSHOP Dr. David Harland, Medical Scientific Liaison, UCB PHARMA,
United Kingdom
8:00 · REGISTRATION AND BREAKFAST FOR
WORKSHOP PARTICIPANTS 14:00 · INVESTIGATOR INITIATED TRIALS (IITs)
Outlining Best Practices for How MSLs and Advisors Can Best
9:00 · PRE-CONFERENCE WORKSHOP: REGULATORY OVERVIEW Support the Successful Execution of IITs across the EU
Understanding Requirements and Ensuring Compliant • Providing insight on study ideas and protocols
External and Internal Communications while Working • Assisting with the internal approval process for investigators who
in a Complex International Environment propose study ideas
• Helping to ensure adherence to study timelines and the meeting
MSLs and MAs/SAs must take great care in knowing and complying
of milestones
with the rules, legislation and codes of practice that are relevant to
• Fostering the relationship between the investigator and the
their roles, so that they do not put themselves, their companies and
sponsoring company
patients at any undue risk. They must be aware of the boundaries of
their positions, especially when interacting with thought leaders in the Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
field as well as with internal commercial teams. The regulations can be
complicated to decipher and apply, and can differ significantly across 14:45 NETWORKING AND REFRESHMENT BREAK
countries throughout the EU. In this workshop, gain practical and
relevant information on:
15:15 · BRAND DEVELOPMENT AND APPROVAL
• Exploring similarities and differences in rules related to industry- Collaborating with Marketing and Sales to Foster Brand
healthcare provider interactions within different EU nations Strategy, Ensure Compliant Promotional Materials, and
• Examining the major regulations and guidance that MSLs must Achieve Corporate Objectives
follow in Europe, including an in-depth discussion of the ABPI
• Informing the planning and development of branded materials
Code of Practice for the Pharmaceutical Industry in the UK
• Reviewing promotional pieces for clinical content and
• Compliantly communicating with internal sales and marketing
compliance with relevant Codes of Practice and regulations before
colleagues
approving their print and distribution
• Developing SOPs within your department to support transpar
• Providing clear and meaningful training to internal teams on
ency and compliance
scientific concepts related to company products
• Do’s and don’ts of responding to requests for off-licence informtion
• Ensuring transparency and quality of cross-functional exchanges
• Outlining the potential consequences of noncompliance
for enhanced information sharing and ultimate achievement of
• Anticipating the future of increased regulation throughout the EU
business goals
Vanessa Young, UK/ROI Medical Liaison Manager, LILLY, United Kingdom Dr. Christian Felter, Director, FELTER CONSULTING LTD, United Kingdom
Dr. Lincoln Tsang, Partner, ARNOLD & PORTER LLP; Nonexecutive Member,
Regulatory Oversight Committee, HEALTH PROTECTION AGENCY; 16:00 · KEY OPINION LEADER INITIATION AND DEVELOPMENT
COUNCIL MEMBER, SCHOOL OF PHARMACY, UNIVERSITY OF LON- Effectively Managing Relationships to Meet the
DON; Commissioner, BRITISH PHARMACOPOEIA COMMISSION, United Needs and Objectives of the KOL and the Company
Kingdom
• Developing a strategy for initiating contact with a new KOL – how
10:30 30-MINUTE NETWORKING & REFRESHMENT BREAK to establish credibility and rapport
• Strengthening communication skills to highlight therapeutic area
12:00 WORKSHOP CONCLUDES expertise and support relationship building
LUNCHEON FOR WORKSHOP PARTICIPANTS • Discussing variations of KOL preferences for information
exchange and how to accordingly tailor communication
MAIN CONFERENCE BEGINS · DAY ONE • Gathering insights from the field to guide future business decisions
Dr. Dale Kummerle, Field Medical Strategy Lead, Virology,
13:00 Chairperson’s Welcome and Opening Remarks
BRISTOL-MYERS SQUIBB, France
Dr. Alan Yong, Medical Affairs Manager Oncology,
GLAXOSMITHKLINE, United Kingdom
16:45
13:15 · DEFINING AND EVALUATING THE ROLE OF THE MSL, MA and SA
Roundtable Sessions with Attendees from the 3rd
Exploring Similarities and Differences in Job Titles, European Investigator-Initiated Trials Conference:
Descriptions and Daily Activities of Medical Science 1 Advisory Board Management: What are best practices for
Liaisons, Medical Advisors, and Scientific Advisors supporting, designing and delivering presentations at advisory
across Companies and Countries boards?
• What nomenclature is most prevalent and accurate to describe 2 Resource Maximisation: How can teams eliminate waste and
field-based versus office-based medical affairs experts? implement changes as budgets continue shrink?
• Outlining the core objectives of professionals in the above stated 3 Small Company Challenges: How can MSLs and Advisors best
positions and how their activities differ manage unique challenges that coincide with working at a
• What different educational backgrounds are most commonly smaller company?
associated and necessary for each role? 4 Team Management: What criteria should determine how MSLs/
• Describing short-term and long-term goals and responsibilities Advisors are deployed and how can management support the
goals of the individual team member, the department and the
Marc Van Melckenbeke, Senior Global Director Medical Communication & company?
Coordination, Global Medical Affairs, UCB PHARMA, Belgium

4. Conference Agenda
5 Team Characteristics: What value do different educational 11:00 · CORPORATE BUSINESS OBJECTIVES
degrees, professional background and skills bring and how should Aligning the Activities and Goals of Field Based Teams for
this impact recruitment decisions? Strengthened Corporate Sustainability
6 Pharmacovigilance: How can MSLs/Advisors most effectively
support drug safety? • Examining the disconnect between field based medical and
corporate initiatives
17:45 CLOSE OF DAY ONE • Acquiring and synthesizing field insights to drive clinical and
corporate decision-making
• Demonstrating value of the expensive MSL and Advisor roles to
MAIN CONFERENCE · DAY TWO the company
7:00 BREAKFAST FOR CONFERENCE PARTICIPANTS
Dr. Samuel Dyer, Former Senior Regional Medical Director, GENENTECH,
United States
8:00 Chairperson’s Recap of Day One and Moderators’
Key Points from Roundtable Discussions 11:45 LUNCHEON
Dr. Alan Yong, Medical Affairs Manager Oncology,
GLAXOSMITHKLINE, United Kingdom 12:45 · CASE STUDY: FORMULARY DISCUSSIONS
8:15 · OFF-LICENCE INFORMATION Supporting Reimbursement Teams in Demonstrating
Clinical Value to Payers
Compliantly Responding to Unsolicited Questions and
Establishing Parameters for Off-Label Discussions • Involving MSLs/Advisors early in the process to best facilitate
formulary negotiations
• Defining what “off-licence” and “unsolicited request” mean to • Proactively providing scientific information to educate health
your company care payers
• Discussing benefits versus risks to the franchise when • Improving communication between internal teams for stronger
establishing SOPs for off-licence requests value demonstrations
• Exploring strategies for handling requests that physicians make • How is the role of the health care payer changing and is there a
to sales need for a dedicated sub-speciality of MSLs/Advisors?
• Determining what information needs to be included when
documenting requests and conversations Becky Reeve, Scientific Advisor Manager, Cardiovascular &
• Examining the regulations surrounding off-licence information Metabolism SAMs, SANOFI-AVENTIS, United Kingdom
dissemination and considering the penalties and damage to the
company of noncompliance 13:30 · CAREER DEVELOPMENT
Dr. Nikki Church, Senior Medical Advisor, General Medicine, Identifying Different Opportunities Available to Individuals
BAYER, United Kingdom with MSL/Advisor Experience, Education Levels and Skills
• Considering different positions within the company and
9:00 · COMPLIANCE AND TECHNOLOGY industry that are aligned with the qualifications of MSLs and Advisors
Utilizing Technology to Increase Efficiency, Minimise Risk • Being a champion of your own growth
and Manage Compliance Requirements • Engaging in preceptorships, networking events and shadowing
activities to refine interests and learn more about different roles
• Exploring strategies for how to effectively document off-licence • Determining when the right time is to make a change
information requests
• Implementing a system for enhanced management and selection Dr. Chris Sugg, Senior Regional Medical Liaison,
of KOLs AMGEN GLOBAL ONCOLOGY SCIENTIFIC AFFAIRS, United States
• Gathering and synthesizing field insights and internal
communications to benefit both field and office based colleagues 14:15 · PANEL DISCUSSION
9:45 NETWORKING AND REFRESHMENT BREAK How Can Field-Based and Office-Based Medical Affairs
Colleagues Best Support Each Other in their Roles?
10:15 · PERFORMANCE EVALUATION • What kinds of field insights are valuable for MSLs to bring back
to SAs and MAs?
Selecting Qualitative and Quantitative Metrics to
• How can brand information acquired internally be
Demonstrate the Value of the MSL or Advisor
communicated to field based medical to support their activities
• Weighing the challenges and benefits of qualitative and with KOLs?
quantitative metrics • How can teams ensure meaningful collaboration to support
• Discussing specific metrics that have proven results of effectively corporate objectives?
assessing performance
• Planning ahead for success by setting targets and agreeing on Panelists:
performance goals Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Medical
• Ensuring that selected metrics are compliant and not tied to direct Centre of Excellence, BRISTOL-MYERS SQUIBB, France
sales generated for the company Marc Van Melckenbeke, Senior Global Director Medical Communication &
Coordination, Global Medical Affairs, UCB PHARMA, Belgium
Dr. Drew Macgregor, EU Field Medical Operations Manager, EU Field Interested in joining this panel discussion? Please contact Lindsay Slater at
Medical Centre of Excellence, BRISTOL-MYERS SQUIBB, France lslater@exlpharma.com for more information.
15:00 CLOSE OF CONFERENCE

5. Sponsorship and Exhibiting Opportunities
Do you want to spread the word about your organisation’s solutions and services to potential clients who will
be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a
networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to
customize a package that will suit all of your needs. To learn more about these opportunities, please contact:
Lucas Carrasco, business Development manager
+1 212-400-6231, lcarrasco@exlpharma.com
MeDIA PARtneRS FIVe WAYS to ReGISteR
Fax: +1 212-400-9408
Mail: ExL Events, Inc.
555 8th Ave, Ste 310
New York, NY 10018
Phone: +1 212-400-6240
Online: www.exlpharma.com
Email: register@exlpharma.com
EARLY BIRD PRICING
Register by Friday, 17 September 2010 to Take Advantage
of Early-Bird Pricing:
Conference + Workshop £1,450
Conference Only £1,300
STANDARD PRICING
Register After Friday, 17 September 2010:
Conference + Workshop £1,600
Conference Only £1,450
ONSITE PRICING
Conference + Workshop £1,750
Conference Only £1,600
GRoUP DISCoUnt PRoGRAM:
Save 25% per person when Registering Four
For every three simultaneous registrations from your company, you will receive a fourth
complimentary registration to the program (must register 4 at one time). This is a savings
of 25% per person.
Save 15% per person when Registering Three
Can only send three? You can still save 15% off of every registration. To find out more on
how you can take advantage of these group discounts, please call + 1 212-400-6240.
Important! Discounts may not be combined. Discount only applies to standard rate. Make checks payable to ExL
Events, Inc. and write code P1122 on your check. You may also use Visa, MasterCard, Discover or American Express.
Payments must be received in full prior to the commencement of the conference.
Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following
policies derived from the Start Date of the event:
Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two
years from the voucher issue date. Four weeks or Less: A voucher to another ExL event valid for two years from the
voucher issue date. To receive a refund or voucher, please fax your request to +1 212-400-9408.
Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend.
There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a
colleague occurring within five business days of any ExL conference.
Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the
replacement attendee.
Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation,
every effort to find a suitable replacement will be made.
*The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.*
To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl

6. REGISTER bY 17TH SEPTEMbER FOR REDUcED PRIcING
Medical/Scientific Advisor
and Medical Science
PLEASE MENTION PRIORITY CODE: P1122
Exp. Date:
PROUDLY PRESENTS
Liaison Best Practices
555 8th Avenue, Suite 310
New York, NY 10018
Bringing Maximum Value to the KOL,
Company and Industry
28-29 OCTObER 2010, AmbASSADORS bLOOmSbURy HOTEL, LONDON
FEATURED SESSIONS INCLUDE:
Distinguished
Name on Card
Speaking Faculty DEFINING AND EVALUATING THE ROLE OF THE MSL, MA AND SA
Card Number
Signature
Exploring Similarities and Differences in Job Titles, Descriptions and
Joins Us From: Daily Activities of Medical Science Liaisons, Medical Advisors, and
Scientific Advisors across Companies and Countries
AMGEN Marc Van Melckenbeke, Senior Global Director Medical Communication & Coordination, Global
ARNOLD & PORTER Medical Affairs, UCB PHARMA, BELGIUM
BAYER Dr. David Harland, Medical Scientific Liaison, UCB PHARMA, United Kingdom
Please contact me: I’m interested in marketing opportunities at this event
BRISTOL-MYERS SQUIBB INVESTIGATOR INITIATED TRIALS (IITs)
register@exlpharma.com
I wish to receive email updates on ExL Pharma’s upcoming events
BRITISH PHARMACOPOEIA Outlining Best Practices for How MSLs and Advisors Can Best Support
www.exlpharma.com
Zip
the Successful Execution of IITs across the EU
COMMISSION
Dr. Sarah Peachey, Medical Manager, PFIZER, United Kingdom
888-221-6750
FELTER CONSULTING LTD
FORMER GENENTECH KEY OPINION LEADER INITIATION AND DEVELOPMENT
Yes! Register me for the Main Conference
GLAXOSMITHKLINE Effectively Managing Relationships to Meet the Needs and Objectives
State
Title
of the KOL and the Company
Fax
LILLY
Dr. Dale Kummerle, Field Medical Strategy Lead, Virology, BRISTOL-MYERS SQUIBB, France
PFIZER
SANOFI-AVENTIS cAREER DEVELOPMENT
Corporate Rate: Main Conference
UCB Identifying Different Opportunities Available to Individuals with
Corporate Rate: Plus Workshop
AND MORE! MSL/Advisor Experience, Education Levels and Skills
Dr. Chris Sugg, Senior Regional Medical Liaison, AMGEN GLOBAL ONCOLOGY SCIENTIFIC
New York, NY 10018
TO R E G I S T E R
AFFAIRS, United States
555 8th Avenue,
ExL Events, Inc.
and Workshop
866-207-6528 The Only Event Led by, and Designed for,
Suite 310
European Pharmaceutical, Biotech and
Medical Device Advisors and MSLs!
Telephone
Company
Address
Name
Email
Dept.
City
To Register call +1 212-400-6240 or visit us at www.exlpharma.com/euromsl